Logo for Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals Investor Relations Material

Latest events

Logo for Hikma Pharmaceuticals PLC

H2 2023 (Q&A)

Hikma Pharmaceuticals
Logo for Hikma Pharmaceuticals

H2 2023 (Q&A)

22 Feb, 2024
Logo for Hikma Pharmaceuticals

H2 2023

22 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Hikma Pharmaceuticals PLC

Access all reports
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company's non-specialty portfolio includes drugs treating diabetes, heart disease, pain management, respiratory disease and other disorders for adults as well as children. The company operates as a regional pharmaceutical company that develops, manufactures, markets and sells a range of generic, branded and its in-licensed products from pain management to oncology.